Article Sidebar
Published:
Feb 4, 2023Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
A bioinformatics approach to the identification of hub genes of Huo Xin Pill (HXP) for the treatment of acute myocardial infarction
Abstract
Purpose: To apply bioinformatics for the identification of potential genes associated with Huo Xin Pill (HXP), a traditional Chinese medicine (TCM) used for the treatment of acute myocardial infarction AMI).
Methods: Mouse AMI expression profile dataset GSE153485 and HXP-treated mouse AMI expression profile dataset GSE147365 were downloaded from GEO database. Then, R software was used to screen differentially-expressed genes in AMI and differentially-expressed genes in HXP-treated AMI. Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses, Venn diagrams, and protein-protein interaction (PPI) analysis were carried out on the hub genes linked to the effect of HXP on AMI.
Results: Six hub genes were identified. Based on the differential analysis of the sham and AMI groups, GSE153485 and GSE147365 had 840 and 2116 differentially-expressed genes, respectively (p < 0.05). The GO and KEGG analyses revealed enrichments in actin filament organization, membrane repolarization, and regulation of the actin cytoskeleton. Differential analysis of the use of HXP on AMI showed that GSE147365 had 380 differentially-expressed genes, comprising 96 up-regulated genes and 284 down-regulated genes (p < 0.05). Thirteen potential acting target genes were obtained using a enn diagram, while 6 key acting genes were obtained via final screening.
Conclusion: Six (6) hub genes linked to HXP and AMI have been identified using bioinformatics: Egr2, Tubb2a, Col4a2, Cnn2, Lmna, and Col4a1. This study provides a partial experimental basis for the use of HXP in the treatment of AMI. In addition, it provides new potential targets for the treatment of AMI.
